Medicamen Biotech Live Share Price Today, Share Analysis and Chart

Name: Medicamen Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Medicamen Biotech Ltd.
Rating: 2.815416625
Author: Trendlyne DVM scores

Mid-range Performer

about

Medicamen Biotech Limited (MBL) is an India-based pharmaceutical company primarily engaged in the development, manufacturing, and marketing of a wide range of generic pharmaceutical formulations. The company holds a significant position in both gener...

260.90 4.15 (1.62%)

New 52W Low in past week

28,668

NSE+BSE Volume

NSE 03 Jul, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

35.9 / 100

Mid-range Performer These stocks have strong quality. Their reasonable financials and technicals make them potentially attractive to investors View Similar Embed DVM

No estimates available

Medicamen Biotech Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Medicamen Biotech Ltd. worth buying?

39 Votes:

Buy 76.92%

Sell 17.95%

Hold 5.13%

Medicamen Biotech Live Share Price Today, Share Analysis and Chart

Medicamen Biotech Limited (MBL) is an India-based pharmaceutical company primarily engaged in the development, manufacturing, and marketing of a wide range of generic pharmaceutical formulations. The company holds a significant position in both gener...

New 52W Low in past week

SWOT Analysis

Medicamen Biotech Live Price Chart

Medicamen Biotech Live Price Chart